Approvals/TGA/IRBESARTAN/HCT SANDOZ 150/12.5 irbesartan 150 mg/hydrochlorothiazide 12.5 mg film-coated tablet blister pack

Approved

STANDARD

IRBESARTAN/HCT SANDOZ 150/12.5 irbesartan 150 mg/hydrochlorothiazide 12.5 mg film-coated tablet blister pack

Sandoz Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: fba6e6a0cb64d4ff
Product Name: IRBESARTAN/HCT SANDOZ 150/12.5 irbesartan 150 mg/hydrochlorothiazide 12.5 mg film-coated tablet blister pack
Artg Id: 174729
Artg Name: IRBESARTAN/HCT SANDOZ 150/12.5 irbesartan 150mg / hydrochlorothiazide 12.5mg film coated tablet blister pack
Sponsor: Sandoz Pty Ltd
Company Detail Path: /organization/sandoz-pty-ltd
Artg Date: 2011-10-28
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: https://medical-cdn.nocode.com/drug_tga/a524cf7a9bbe622290a30bff113ca6ae.pdf
Product Information: https://medical-cdn.nocode.com/drug_tga/bb52a3804f6057d5ad5c967993640d4a.pdf

Approved

Agency

TGA

Country

🇦🇺

Approval Date

May 29, 2025

Approval ID

fba6e6a0cb64d4ff

Type

Standard